Rectal MRI for Cancer Staging and Surveillance
- Courtney C. Moreno(corresponding author),
- Patrick S. Sullivan,
- Emory University
Scholary Output:
Contribution to journal
Review article
Peer-reviewSustainable Development Goals
- SDG 3 Good Health and Well
Abstract
MRI is an integral part of the multidisciplinary treatment of rectal adenocarcinoma. Staging MRI is performed to establish TNM stage and assess for prognostic factors, including circumferential resection margin status and presence of extramural vascular invasion. The results of staging MRI determine which patients will undergo preoperative neoadjuvant chemoradiation before resection. Restaging MRI is performed to evaluate for treatment response and may identify patients with no residual visible tumor who are candidates for a “watch and wait” strategy in lieu of resection. In addition, the results of MRI in conjunction with endoscopy determine the surgical technique used to remove the tumor.
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 537-552 (16 pages)Journal (Volume, Issue Number)
Gastroenterology Clinics of North America (Volume 47, Issue 3)Publication milestones
- Accepted/In press - 01/01/2018
- Published - 09/2018
Publication status
Published - 09/2018
ISSN
0889-8553Publication IDs
- Scopus: 85049342044
- PubMed: 30115436
Publication metrics
Metrics
SciVal
citations
8
SciVal
FWCI
0.55
SciVal
Author count
3
SciVal
Paper percentile
76
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
22
Captures
41
